These compounds may interact with:
15-hydroxyprostaglandin dehydrogenase [NAD(+)]
Potentially involved in: primary hypertrophic osteoarthropathy; cancer; intestinal benign neoplasm; arachnodactyly; arthralgia; arthritis; blepharoptosis; congenital clubfoot; patent ductus arteriosus; eczema; hyperhidrosis disorder; arthropathy; palmoplantar keratosis; degenerative polyarthritis; osteoarthropathy, primary hypertrophic; osteomyelitis; osteopenia; osteoporosis; prostatic neoplasms; seborrheic dermatitis
Disease data sourced from Pharos.